KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Change in Receivables: 2009-2025

Historic Change in Receivables for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $218.0 million.

  • Bausch Health Companies' Change in Receivables rose 1047.83% to $218.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $303.0 million, marking a year-over-year increase of 131.30%. This contributed to the annual value of $216.0 million for FY2024, which is 10.77% up from last year.
  • According to the latest figures from Q3 2025, Bausch Health Companies' Change in Receivables is $218.0 million, which was up 139.56% from $91.0 million recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Change in Receivables ranged from a high of $231.0 million in Q3 2023 and a low of -$197.0 million during Q1 2022.
  • In the last 3 years, Bausch Health Companies' Change in Receivables had a median value of $63.0 million in 2024 and averaged $55.5 million.
  • Data for Bausch Health Companies' Change in Receivables shows a peak YoY increase of 1,047.83% (in 2025) and a maximum YoY decrease of 274.60% (in 2025) over the last 5 years.
  • Bausch Health Companies' Change in Receivables (Quarterly) stood at $52.0 million in 2021, then crashed by 40.38% to $31.0 million in 2022, then crashed by 38.71% to $19.0 million in 2023, then skyrocketed by 447.37% to $104.0 million in 2024, then surged by 1,047.83% to $218.0 million in 2025.
  • Its Change in Receivables stands at $218.0 million for Q3 2025, versus $91.0 million for Q2 2025 and -$110.0 million for Q1 2025.